Literature DB >> 236841

Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension.

E L Bravo, R C Tarazi, H P Dustan, J W Lewis.   

Abstract

Studies were carried out in 69 patients with essential hypertension to examine the relationship between changes in plasma renin activity (PRA) and arterial pressure (BP) in response to a beta-adrenergic blocking agent, propranolol. PRA had no consistent relationship with BP during treatment, either in patients receiving propranolol alone (r = 0.12) or in those receiving a combination of diuretics and propranolol (r = 0.18). Furthermore, long-term beta-adrenergic blockade failed to inhibit increases of PRA induced by diuretics or rapid sodium depletion. These results indicate that (1) beta-adrenergic blockade can reduce BP by mechanisms other than PRA suppression; and (2) the beta-adrenergic nervous system is important, but not essential, for renin release.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236841     DOI: 10.1161/01.res.36.6.241

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

1.  The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.

Authors:  G S Stokes; R M Graham; M A Weber
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

4.  [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].

Authors:  P Weidmann; C Beretta-Piccoli; W Ziegler; D Hirsch; R D de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1976-08-15

Review 5.  New drugs in hypertension.

Authors:  M G Myers
Journal:  Can Med Assoc J       Date:  1977-01-22       Impact factor: 8.262

6.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

Authors:  B G Hansson; J F Dymling; H Hedeland; U L Hulthén
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

7.  Pharmacokinetics of atenolol in patients with renal impairment.

Authors:  J Sassard; N Pozet; J McAinsh; J Legheand; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

Review 8.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Relationship between kallikrein and PRA after intravenous furosemide.

Authors:  G A Cinotti; G Stirati; F Taggi; R Ronci; B M Simonetti; A Pierucci
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

Review 10.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.